Crossmark

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-018-0367-2

Published Online: 2018-10-18

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shah, Mithun Vinod

Saliba, Rima M.

Rondon, Gabriela

Chen, Julianne

Soebbing, Doris

Rus, Ioana

Alousi, Amin

Oran, Betul

Kebriaei, Partow

Qazilbash, Muzaffar https://orcid.org/0000-0003-2876-2886
Parmar, Simrit

Hosing, Chitra

Khouri, Issa F.

Popat, Uday R.

Champlin, Richard E.

Ciurea, Stefan O.
License Information

Text and Data Mining valid from 2018-10-18
More Information

Article History

Received: 24 March 2018

Revised: 28 August 2018

Accepted: 23 September 2018

First Online: 18 October 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below